Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioDelivery Sciences International Inc (NASDAQ:BDSI)

2.35
Delayed Data
As of May 22
 0.00 / 0.00%
Today’s Change
1.50
Today|||52-Week Range
3.10
+34.29%
Year-to-Date
2 Oversold Biopharmas With Big 2017 Upsides
May 22 / TheStreet.com - Paid Partner Content
3 Small Biotech Value Plays
May 17 / TheStreet.com - Paid Partner Content
BioDelivery Sciences International (BDSI) Jumps: Stock Up 5%
May 18 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) Q1 Earnings Beat Estimates, Stock Gains
May 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close2.35
Today’s openn.a.
Day’s range-- - --
Volume2,500
Average volume (3 months)532,301
Market cap$135.5M
Dividend yield--
Data as of 05/22/2017

Growth & Valuation

Earnings growth (last year)-73.61%
Earnings growth (this year)+104.46%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-67.77%
P/E ratioNM
Price/Sales6.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MSLIMerus Labs Internati...0.000.00%
--EcoGreen Internation...+0.00+0.55%
CRMECardiome Pharma Corp0.000.00%
ALBOAlbireo Pharma Inc0.000.00%
Data as of 05/22/2017

Financials

Last reporting dateMay 15, 2017
EPS forecast (this quarter)$0.12
Annual revenue (last year)$15.5M
Annual profit (last year)-$67.1M
Net profit margin-431.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Vice Chairman, President &
Chief Executive Officer
Mark A. Sirgo
CFO, Principal Accounting Officer &
Secretary
Ernest R. de Paolantonio
Corporate headquarters
Raleigh, North Carolina

Forecasts